Lab News

Collaboration with Ionis Pharmaceuticals on new therapies for neurodevelopment disorders

We’re thrilled to have entered into a sponsored research agreement with Ionis Pharmaceuticals, the leading experts on antisense technology.  The partnership will be between Ionis and the Prosser and Davidson labs at Penn and CHOP, respectively, and is focused on testing a new approach to treat STXBP1 disorders using antisense oligonucleotides.


About the Author

The Author has not yet added any info about himself